SLP INVESTORS: Simulations Plus, Inc. Investors are Reminded to Contact BFA Law about its Ongoing Securities Fraud Investigation - Seite 2

However, Simulations Plus also revealed that the auditor disagreed with the Company's characterizations and that, according to Grant Thornton, "[it] identified and communicated certain matters to management and the Audit Committee related to segment reporting and reporting unit determinations as well as internal controls over financial reporting. . . . These matters were not resolved to our satisfaction as of the date of our termination."

On the news of the impairment charge, the dismissal of Grant Thornton, and the auditor's findings, the price of Simulation Plus stock declined $4.50 per share, nearly 26%, from $17.47 per share on June 14, 2025, to $12.97 per share on June 15, 2025.

Click here for more information: https://www.bfalaw.com/cases/simulations-plus-inc-class-action-lawsuit.

What Can You Do?

If you invested in Simulations Plus you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/simulations-plus-inc-class-action-lawsuit

Or contact:
Ross Shikowitz
[e-mail]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/simulations-plus-inc-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265191

The Simulations Plus Stock at the time of publication of the news with a fall of -1,27 % to 13,94USD on Nasdaq stock exchange (05. September 2025, 21:24 Uhr).